This document is the official Egyptian guideline for the Medical Device Vigilance System. Issued by the Egyptian Drug Authority (EDA), it establishes the mandatory framework for monitoring the safety and performance of medical devices after they have been approved and are being used in the Egyptian market. Its primary goal is to protect patient and user health by ensuring that any risks associated with medical devices are quickly identified, investigated, and addressed.
The guideline outlines the roles and responsibilities of all parties involved and sets the procedures for reporting and managing incidents, ensuring compliance with both national and international best practices.
Key Objectives
The system is designed to:
- Improve health and safety by preventing the recurrence of adverse events.
- Enable regulatory oversight by allowing the EDA to monitor how manufacturers handle safety issues.
- Facilitate rapid action when a device is found to be faulty or risky.
- Inform healthcare professionals and users so they can take necessary steps to ensure safety.
Scope
This guideline applies to all medical devices, including In-Vitro Diagnostic (IVD) devices, marketed in Egypt. It covers both:
- Pre-market requirements: Conditions for initial device registration.
- Post-market requirements: Ongoing surveillance after the device is available for use.
Core Components and Responsibilities
The document is structured around the duties of three main stakeholders:
1. Responsibilities of Users (Healthcare Professionals & Facilities)
- Report Feedback: Users are encouraged to report any issues, complaints, or incidents (both positive and negative) to the manufacturer and directly to the Medical Device Safety Unit (MDSU) using specific forms.
- Proper Use and Storage: They must use and store devices according to the manufacturer’s instructions.
- Preserve Evidence: In case of an incident, they must safely store the affected device and related materials for investigation and not repair or discard it.
- Implement Field Safety Actions: They must act on Field Safety Notices (FSNs) issued by manufacturers, such as returning or modifying a device.
2. Responsibilities of Manufacturers (The Core of Vigilance)
This is the most detailed section, requiring manufacturers to:
- Pre-Market Requirements: Submit specific safety reports (like a Periodic Safety Update Report – PSUR) as part of the device registration process, especially for higher-risk devices.
- Post-Market Surveillance (PMS) System:
- PMS Plan: Have a proactive plan to continuously collect and review data on their device’s safety and performance.
- PMS Report (PMSR) / Periodic Safety Update Report (PSUR): Regularly prepare and submit reports summarizing their findings from PMS data. The frequency depends on the device’s risk class (e.g., annually for high-risk devices).
- Incident Reporting and Investigation:
- What to Report: Any serious incident that leads to or could have led to death, serious health deterioration, or a serious public health threat.
- When to Report: Strict timelines are enforced:
- Serious Public Health Threat: Within 2 days.
- Death or Unanticipated Serious Injury: Within 10 days.
- Other Serious Incidents/Near-Incidents: Within 15 days.
- How to Report: Using the Manufacturer Incident Report (MIR) form to the MDSU.
- Investigation: Manufacturers must investigate the root cause of all serious incidents.
- Corrective Actions:
- If a risk is confirmed, the manufacturer must implement a Field Safety Corrective Action (FSCA), such as a device recall, modification, or update to instructions.
- This action is communicated to users via a Field Safety Notice (FSN), which must be approved by the MDSU.
3. Responsibilities of the Medical Device Safety Unit (MDSU)
The MDSU is the regulatory body within the EDA that manages the entire system. Its duties include:
- Collecting Reports: Receiving incident reports from both users and manufacturers.
- Encouraging Reporting: Running campaigns to promote voluntary reporting of adverse events.
- Assessing Risks: Evaluating reported incidents and the manufacturers’ proposed corrective actions.
- Monitoring and Enforcement: Overseeing manufacturers’ investigations and ensuring they comply with the guidelines.
- Information Dissemination: Communicating safety information to healthcare professionals and the public when necessary.
- International Cooperation: Exchanging safety information with regulatory authorities in other countries.
Conclusion
In essence, this document provides the complete rulebook for medical device safety in Egypt after a device is sold. It creates a closed-loop system where:
- Problems are reported by users or identified by manufacturers.
- Risks are investigated thoroughly to find the root cause.
- Actions are taken to correct the problem and prevent it from happening again.
- The regulator (MDSU) oversees the entire process to ensure public safety.
By implementing this vigilance system, Egypt aims to ensure that medical devices used within its borders remain safe, effective, and trustworthy throughout their entire lifecycle.
